{
    "root": "1305687e-4ede-41f0-8e12-b1d8d8188349",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Digoxin",
    "value": "20250520",
    "ingredients": [
        {
            "name": "DIGOXIN",
            "code": "73K4184T59"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "SODIUM PHOSPHATE, DIBASIC, ANHYDROUS",
            "code": "22ADO53M6F"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "CITRIC ACID MONOHYDRATE",
            "code": "2968PHW8QP"
        },
        {
            "name": "SODIUM PHOSPHATE",
            "code": "SE337SVY37"
        }
    ],
    "indications": "digoxin cardiac glycoside indicated : • treatment mild moderate heart failure adults . ( 1.1 ) • control resting ventricular rate adults chronic atrial fibrillation . ( 1.2 )",
    "contraindications": "digoxin dose based patient-specific factors ( age , lean body weight , renal function , etc . ) . full prescribing information . monitor toxicity therapeutic effect . ( 2 ) intravenous preferable intramuscular . avoid bolus . ( 2 )",
    "warningsAndPrecautions": "digoxin injection , usp available : 500 mcg/2 ml ( 250 mcg/ml ) ampuls packaged : overbagged 5 x 2 ml ampuls bag , ndc 55154-5106-5 warning : unit dose package child resistant intended institutional . keep drugs reach children . store 20˚ 25˚c ( 68˚ 77˚f ) , excursions permitted 15˚ 30˚c ( 59˚ 86˚f ) [ usp controlled room temperature ] . protect light .",
    "adverseReactions": "digoxin contraindicated patients : •ventricular fibrillation [ ( 5.1 ) ] •known hypersensitivity digoxin ( seen include unexplained rash , swelling mouth , lips throat difficulty breathing ) . hypersensitivity reaction digitalis preparations usually constitutes contraindication digoxin .",
    "indications_original": "Digoxin is a cardiac glycoside indicated for: • Treatment of mild to moderate heart failure in adults. ( 1.1 ) • Control of resting ventricular rate in adults with chronic atrial fibrillation. ( 1.2 )",
    "contraindications_original": "Digoxin dose is based on patient-specific factors (age, lean body weight, renal function, etc.). See full prescribing information. Monitor for toxicity and therapeutic effect. ( 2 ) Intravenous administration is preferable to intramuscular. Avoid bolus administration. ( 2 )",
    "warningsAndPrecautions_original": "Digoxin Injection, USP is available as:\n                  500 mcg/2 mL (250 mcg/mL) ampuls packaged:\n                  Overbagged with 5 x 2 mL ampuls in each bag, NDC 55154-5106-5\n                  WARNING: This Unit Dose package is not child resistant and is Intended for Institutional Use Only. Keep this and all drugs out of the reach of children.\n                  \n                     Store at 20˚ to 25˚C (68˚ to 77˚F), excursions permitted to 15˚ to 30˚C (59˚ to 86˚F) [see USP Controlled Room Temperature]. Protect from light.",
    "adverseReactions_original": "Digoxin is contraindicated in patients with:\n                  \n                     \n                        •Ventricular fibrillation [see Warnings and Precautions (5.1)]\n                     \n                     \n                        •Known hypersensitivity to digoxin (reactions seen include unexplained rash, swelling of the mouth, lips or throat or a difficulty in breathing). A hypersensitivity reaction to other digitalis preparations usually constitutes a contraindication to digoxin."
}